Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
Clinical trial NCT03279692 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03279692
- Sponsor
- Massachusetts General Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-07
- Primary completion
- 2021-09-18
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.